Cooley advised Kriya Therapeutics on the deal.Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing round. …
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
